Crossmark

Randomized Comparison Study of Novel Recombinant Human Antithrombin Gamma and Plasma-Derived Antithrombin in Healthy Volunteers

Published Online: 2019-09-06

Published Print: 2019-12

Authors

Furuie, Hidetoshi

Kanda, Hironori
Funding

Funding for this research was provided by:

Kyowa Hakko Kirin Co., Ltd
License Information

Text and Data Mining valid from 2019-09-06

Version of Record valid from 2019-09-06
More Information

Article History

First Online: 6 September 2019

Compliance with Ethical Standards

:

: This study was funded by Kyowa Kirin Co., Ltd.

: Hidetoshi Furuie has received consulting/lecture fees and research funding from Kyowa Kirin Co., Ltd. Hironori Kanda is an employee of Kyowa Kirin Co., Ltd.

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Institutional Review Board at Osaka Pharmacology Clinical Research Hospital, Osaka, Japan (approval no. 787PC and no. 814PC) and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.

Document is current